Searching for Grendel: Origin and global spread of the C9ORF72 repeat expansion

Acta Neuropathologica

Volumn 127, Issue 3, 2014, Pages 391-396

  Pliner, Hannah A ^a   Mann, David M ^b   Traynor, Bryan J ^a,c  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; C9ORF72 GENE; EUROPE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC DRIFT; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HUMAN; MORBIDITY; PRIORITY JOURNAL; SHORT TANDEM REPEAT;

AMYOTROPHIC LATERAL SCLEROSIS; DNA REPEAT EXPANSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; EVOLUTION, MOLECULAR; HUMAN MIGRATION; HUMANS; INTERNATIONALITY; PROTEINS; TIME FACTORS;

EID: 84896703334     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1250-x     Document Type: Article

References (38)

1. Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, Sidle K, Polke JM, Houlden H, Schott JM, Fox NC, Rossor MN, Tabrizi SJ, Isaacs AM, Hardy J, Warren JD, Collinge J, Mead S (2013) Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet 92(3):345-353. doi: 10.1016/j.ajhg.2013.01.011
2. Chiò A, Calvo A, Mazzini L, Cantello R, Mora G, Moglia C, Corrado L, D'Alfonso S, Majounie E, Renton A, Pisano F, Ossola I, Brunetti M, Traynor BJ, Restagno G, Parals (2012) Extensive genetics of ALS: a population-based study in Italy. Neurology 79(19):1983-1989. doi: 10.1212/WNL.0b013e3182735d36
3. Colombo R, Tavian D, Baker MC, Richardson AM, Snowden JS, Neary D, Mann DM, Pickering-Brown SM (2009) Recent origin and spread of a common Welsh MAPT splice mutation causing frontotemporal lobar degeneration. Neurogenetics 10(4):313-318. doi: 10.1007/s10048-009-0189-x
4. Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, Martindale J, Hartley J, Walsh T, Gelsthorpe C, Baxter L, Forster G, Fox M, Bury J, Mok K, McDermott CJ, Traynor BJ, Kirby J, Wharton SB, Ince PG, Hardy J, Shaw PJ (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 135(Pt 3):751-764. doi: 10.1093/brain/awr365
5. Cronin S, Hardiman O, Traynor BJ (2007) Ethnic variation in the incidence of ALS: a systematic review. Neurology 68(13):1002-1007. doi: 10.1212/01.wnl.0000258551.96893.6f
6. Daniels R (2002) Coming to America: A history of immigration and ethnicity in American life, 2nd edn. Harper Perennial, New York
7. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245-256. doi: 10.1016/j.neuron.2011.09.011
8. Donnelly CJ, Zhang PW, Pham JT, Heusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, Maragakis N, Tienari PJ, Petrucelli L, Traynor BJ, Wang J, Rigo F, Bennett CF, Blackshaw S, Sattler R, Rothstein JD (2013) RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80(2):415-428. doi: 10.1016/j.neuron.2013.10.015
9. Gijselinck I, Van Langenhove T, van der Zee J, et al. (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11(1):54-65. doi: 10.1016/S1474-4422(11) 70261-7
10. Harms MB, Cady J, Zaidman C, Cooper P, Bali T, Allred P, Cruchaga C, Baughn M, Libby RT, Pestronk A, Goate A, Ravits J, Baloh RH (2013) Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis. Neurobiol Aging 34(9): 2234 e2213-e2239. doi: 10.1016/j.neurobiolaging.2013.03.006
11. Herdewyn S, Zhao H, Moisse M, Race V, Matthijs G, Reumers J, Kusters B, Schelhaas HJ, van den Berg LH, Goris A, Robberecht W, Lambrechts D, Van Damme P (2012) Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis. Hum Mol Genet 21(11):2412-2419. doi: 10.1093/hmg/dds055
12. Ikeda Y, Dalton JC, Moseley ML, Gardner KL, Bird TD, Ashizawa T, Seltzer WK, Pandolfo M, Milunsky A, Potter NT, Shoji M, Vincent JB, Day JW, Ranum LP (2004) Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet 75(1):3-16. doi: 10.1086/422014
13. Imbert G, Kretz C, Johnson K, Mandel JL (1993) Origin of the expansion mutation in myotonic dystrophy. Nat Genet 4(1):72-76. doi: 10.1038/ng0593-72
14. Ishiura H, Takahashi Y, Mitsui J, Yoshida S, Kihira T, Kokubo Y, Kuzuhara S, Ranum LP, Tamaoki T, Ichikawa Y, Date H, Goto J, Tsuji S (2012) C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. Arch Neurol 69(9):1154-1158. doi: 10.1001/archneurol2012.1219
15. Jiao B, Tang B, Liu X, Yan X, Zhou L, Yang Y, Wang J, Xia K, Shen L (2013) Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China. Neurobiol Aging. doi: 10.1016/j.neurobiolaging.2013.10.001
16. Kere J (2001) Human population genetics: lessons from Finland. Annu Rev Genomics Hum Genet 2:103-128. doi: 10.1146/annurev.genom.2.1.103
17. Konno T, Shiga A, Tsujino A, Sugai A, Kato T, Kanai K, Yokoseki A, Eguchi H, Kuwabara S, Nishizawa M, Takahashi H, Onodera O (2013) Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72. J Neurol Neurosurg Psychiatry 84(4):398-401. doi: 10.1136/jnnp-2012- 302272
18. Krahe R, Eckhart M, Ogunniyi AO, Osuntokun BO, Siciliano MJ, Ashizawa T (1995) De novo myotonic dystrophy mutation in a Nigerian kindred. Am J Hum Genet 56(5):1067-1074
19. Laaksovirta H, Peuralinna T, Schymick JC, Scholz SW, Lai SL, Myllykangas L, Sulkava R, Jansson L, Hernandez DG, Gibbs JR, Nalls MA, Heckerman D, Tienari PJ, Traynor BJ (2010) Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol 9(10):978-985. doi: 10.1016/S1474-4422(10)70184-8
20. Lund A, Udd B, Juvonen V, Andersen PM, Cederquist K, Davis M, Gellera C, Kolmel C, Ronnevi LO, Sperfeld AD, Sorensen SA, Tranebjaerg L, Van Maldergem L, Watanabe M, Weber M, Yeung L, Savontaus ML (2001) Multiple founder effects in spinal and bulbar muscular atrophy (SBMA, Kennedy disease) around the world. Eur J Hum Genet 9(6):431-436. doi: 10.1038/sj.ejhg.5200656
21. Majounie E, Renton AE, Mok K, et al. (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11(4):323-330
22. Mok K, Traynor BJ, Schymick J, et al. (2012) Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging 33(1): 209 e203-e208. doi: 10.1016/j.neurobiolaging.2011.08.005
23. Murros K, Fogelholm R (1983) Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand 67(1):41-47
24. Neville CE, Mahadevan MS, Barcelo JM, Korneluk RG (1994) High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation. Hum Mol Genet 3(1):45-51
25. Ogaki K, Li Y, Atsuta N, Tomiyama H, Funayama M, Watanabe H, Nakamura R, Yoshino H, Yato S, Tamura A, Naito Y, Taniguchi A, Fujita K, Izumi Y, Kaji R, Hattori N, Sobue G, Japanese Consortium for Amyotrophic Lateral Sclerosis r (2012) Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 33(10):2527 e2511-2526. doi: 10.1016/j.neurobiolaging.2012.05.011
26. Payseur BA, Jing P, Haasl RJ (2011) A genomic portrait of human microsatellite variation. Mol Biol Evol 28(1):303-312. doi: 10.1093/molbev/ msq198
27. Peltonen L, Jalanko A, Varilo T (1999) Molecular genetics of the Finnish disease heritage. Hum Mol Genet 8(10):1913-1923
28. Pickering-Brown S, Baker M, Bird T, Trojanowski J, Lee V, Morris H, Rossor M, Janssen JC, Neary D, Craufurd D, Richardson A, Snowden J, Hardy J, Mann D, Hutton M (2004) Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutation. Am J Med Genet B Neuropsychiatr Genet 125B(1):79-82. doi: 10.1002/ajmg.b.20083
29. Ratti A, Corrado L, Castellotti B, et al. (2012) C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 33 (10):2528 e2527-e2514. doi: 10.1016/j.neurobiolaging.2012.06.008
30. Renton AE, Chiò A, Traynor BJ (2014) State of Play in ALS genetics. Nat Neurosci 17(1):17-23. doi: 10.1038/nn.3584
31. Renton AE, Majounie E, Waite A, et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257-268. doi: 10.1016/j.neuron.2011.09.010
32. Schymick JC, Traynor BJ (2012) Expanding the genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Alzheimers Res Ther 4(4):30. doi: 10.1186/alzrt133
33. Smith BN, Newhouse S, Shatunov A, et al. (2013) The C9ORF72 expansion mutation is a common cause of ALS ± FTD in Europe and has a single founder. Eur J Hum Genet 21(1):102-108. doi: 10.1038/ejhg.2012.98
34. Snowden JS, Harris J, Richardson A, Rollinson S, Thompson JC, Neary D, Mann DM, Pickering-Brown S (2013) Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72. Amyotroph Lateral Scler Frontotemporal Degener 14(3):172-176. doi: 10.3109/21678421.2013.765485
35. Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, Jones M, Gerhard A, Davidson YS, Robinson A, Gibbons L, Hu Q, DuPlessis D, Neary D, Mann DM, Pickering-Brown SM (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135(Pt 3):693-708. doi: 10.1093/brain/awr355
36. Sobrido MJ, Miller BL, Havlioglu N, Zhukareva V, Jiang Z, Nasreddine ZS, Lee VM, Chow TW, Wilhelmsen KC, Cummings JL, Wu JY, Geschwind DH (2003) Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia. Arch Neurol 60(5):698-702. doi: 10.1001/archneur.60.5. 698
37. Traynor BJ (2012) Road to the chromosome 9p-linked ALS/FTD locus. J Neurol Neurosurg Psychiatry 83(4):356-357. doi: 10.1136/jnnp-2012-302429
38. van der Zee J, Gijselinck I, Dillen L, et al. (2013) A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat 34(2):363-373. doi: 10.1002/humu.22244